Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus.

Many patients who have type 2 diabetes mellitus (DM) require several different medications. Although these agents can substantially reduce diabetes-related morbidity and mortality, the extent of treatment benefits may be limited by a lack of treatment adherence. Unfortunately, little information is available on treatment adherence in patients with type 2 DM. Available data indicate substantial opportunity for improving clinical outcomes through improved treatment adherence. Factors that appear to influence adherence include the patient's comprehension of the treatment regimen and its benefits, adverse effects, medication costs, and regimen complexity, as well as the patient's emotional well-being. Outcomes research emphasizes the importance of effective patient-provider communication in overcoming some of the barriers to adherence. This article offers specific suggestions for improving adherence in patients with type 2 DM seen in general clinical practice.

[1]  R. Carney,et al.  Depression and Poor Glycemic Control , 2000 .

[2]  W. Tierney,et al.  Correlates of health care satisfaction in inner-city patients with hypertension and chronic renal insufficiency. , 1995, Social science & medicine.

[3]  R. E. Warren.  The stepwise approach to the management of type 2 diabetes. , 2004, Diabetes research and clinical practice.

[4]  R. Carney,et al.  Depression and Coronary Heart Disease in Women With Diabetes , 2003, Psychosomatic medicine.

[5]  P. Donnan,et al.  Adherence to oral hypoglycaemic agents prior to insulin therapy in Type 2 diabetes , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[6]  B. Mason,et al.  Pharmacists' Interventions Using an Electronic Medication-Event Monitoring Device'S Adherence Data versus Pill Counts , 1993, The Annals of pharmacotherapy.

[7]  P. Donnan,et al.  Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[8]  Todd H Wagner,et al.  Problems paying out-of-pocket medication costs among older adults with diabetes. , 2004, Diabetes care.

[9]  L. Radloff.  The CES-D Scale , 1977 .

[10]  B. Mason,et al.  Assessment of Sulfonylurea Adherence and Metabolic Control , 1995, The Diabetes educator.

[11]  Caitlin E. Ryan,et al.  Electronic monitoring and counseling to improve medication adherence. , 2004, Behaviour research and therapy.

[12]  D. Schillinger,et al.  Association of health literacy with diabetes outcomes. , 2002, JAMA.

[13]  K. Freedland,et al.  Association of Depression and Diabetes Complications: A Meta-Analysis , 2001, Psychosomatic medicine.

[14]  J. Wogen,et al.  Utilization of oral hypoglycemic agents in a drug-insured U.S. population. , 2001, Diabetes care.

[15]  C. Schmid,et al.  Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. , 2002, Diabetes care.

[16]  U. Bergman,et al.  Lack of adherence to lipid-lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, Italy. , 2000, British journal of clinical pharmacology.

[17]  R. Spitzer,et al.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. , 1999, JAMA.

[18]  John D. Piette,et al.  Dimensions of patient-provider communication and diabetes self-care in an ethnically diverse population , 2003, Journal of General Internal Medicine.

[19]  R. Rubin,et al.  Recognizing and treating depression in patients with diabetes , 2004, Current diabetes reports.

[20]  R. Carney,et al.  Effects of Nortriptyline on Depression and Glycemic Control in Diabetes: Results of a Double-blind, Placebo-controlled Trial , 1997, Psychosomatic medicine.

[21]  K A McKibbon,et al.  Interventions for helping patients to follow prescriptions for medications. , 2002, The Cochrane database of systematic reviews.

[22]  PDB5: MEDICATION COMPLIANCE IN TYPE 2 DIABETES SUBJECTS: RETROSPECTIVE DATA ANALYSIS , 2003 .

[23]  K. Langa,et al.  The Health Effects of Restricting Prescription Medication Use Because of Cost , 2004, Medical care.

[24]  J. Mccombs,et al.  Compliance with Sulfonylureas in a Health Maintenance Organization: A Pharmacy Record–Based Study , 1999, The Annals of pharmacotherapy.

[25]  John D. Voss,et al.  The association between diabetes metabolic control and drug adherence in an indigent population. , 2002, Diabetes care.

[26]  D. Singer,et al.  Polypharmacy and medication adherence in patients with type 2 diabetes. , 2003, Diabetes care.

[27]  D. Schillinger,et al.  Closing the loop: physician communication with diabetic patients who have low health literacy. , 2003, Archives of internal medicine.

[28]  James S Goodwin,et al.  Inconsistent use of diabetes medications, diabetes complications, and mortality in older mexican americans over a 7-year period: data from the Hispanic established population for the epidemiologic study of the elderly. , 2003, Diabetes care.

[29]  R. Rubin,et al.  Modeling The Effect of Diabetes Education on Glycemic Control , 1994, The Diabetes educator.

[30]  W. Katon,et al.  The patient-provider relationship: attachment theory and adherence to treatment in diabetes. , 2001, The American journal of psychiatry.

[31]  G. Kephart,et al.  Variation in pharmacy prescription refill adherence measures by type of oral antihyperglycaemic drug therapy in seniors in Nova Scotia, Canada , 2002, Journal of clinical pharmacy and therapeutics.

[32]  M. Tran,et al.  Effects of Once-Daily and Twice-Daily Dosing on Adherence With Prescribed Glipizide Oral Therapy for Type 2 Diabetes , 2002, Southern medical journal.

[33]  A. Paes,et al.  Impact of Dosage Frequency on Patient Compliance , 1997, Diabetes Care.

[34]  J. Cramer.  A Systematic Review of Adherence With Medications for Diabetes , 2004 .

[35]  K. Freedland,et al.  Cognitive Behavior Therapy for Depression in Type 2 Diabetes Mellitus , 1998, Annals of Internal Medicine.

[36]  L. Egede,et al.  Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. , 2002, Diabetes care.

[37]  D. Grobbee,et al.  Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy? , 2003, Pharmacoepidemiology and drug safety.

[38]  A. Beck,et al.  Assessment of depression: the depression inventory. , 1974, Modern problems of pharmacopsychiatry.

[39]  Differential Effect of Diabetes Education on Self-Regulation and Life-Style Behaviors , 1991, Diabetes Care.

[40]  P. Lustman,et al.  Fluoxetine for Depression in Diabetes , 2000 .

[41]  Cindy Farquhar,et al.  3 The Cochrane Library , 1996 .

[42]  Caitlin E. Ryan,et al.  Neuropsychological Correlates of Suboptimal Adherence to Metformin , 2003, Journal of Behavioral Medicine.

[43]  A. Vanderplas,et al.  Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. , 2002, Clinical therapeutics.

[44]  R. Carney,et al.  Depression and poor glycemic control: a meta-analytic review of the literature. , 2000, Diabetes care.

[45]  Garry Welch,et al.  Assessment of Diabetes-Related Distress , 1995, Diabetes Care.

[46]  R. Rubin,et al.  Was Willis right? Thoughts on the interaction of depression and diabetes , 2002, Diabetes/metabolism research and reviews.

[47]  G. Dailey,et al.  Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitus. , 2001, Clinical therapeutics.

[48]  K. Freedland,et al.  Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. , 2000, Diabetes care.

[49]  M. Al-Azri,et al.  The association between satisfaction with services provided in primary care and outcomes in Type 2 diabetes mellitus , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[50]  S. Kaplan,et al.  The Association between Three Different Measures of Health Status and Satisfaction among Patients with Diabetes , 2003, Medical care research and review : MCRR.

[51]  Sarah Parish,et al.  MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.

[52]  G. Nichols,et al.  Ten-year follow-up of antidiabetic drug use, nonadherence, and mortality in a defined population with type 2 diabetes mellitus. , 1999, Clinical therapeutics.

[53]  W. Katon,et al.  Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. , 2000, Archives of internal medicine.

[54]  J. Piette,et al.  Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? , 2000, The American journal of medicine.